Greenwich LifeSciences (GLSI) Proxy filing summary

Executive summary

• Annual meeting set for December 18, 2026, at 9:00 a.m. ET in New York; shareholders vote on four matters.

• Board recommends FOR director elections, auditor ratification and advisory executive compensation; it recommends a 3-year frequency for advisory pay votes.

Voting matters and shareholder proposals

• Five director nominees: David B. McWilliams, Snehal S. Patel, Eric Rothe, F. Joseph Daugherty and Kenneth Hallock; Board recommends FOR each.

• Proposals include ratification of MaloneBailey LLP for FY ending December 31, 2026, and advisory approval of named executive officer compensation; Board recommends FOR both.

• Shareholders are asked to advise on the preferred frequency of executive compensation votes; Board recommends every 3 years.

Board of directors and corporate governance

• Five directors stand for election at the 2026 annual meeting, with Board support for all five nominees.